introduction
Metformin (1,1-dimethylbiguanidine; N,N-dimethylimidodicarbonimidic diamide), C4H11N5, is a substance of the biguanide family, which shows anti-hyperglycemic action. It is employed in the treatment of hyperglycemia, and more specifically in the treatment of type-2 diabetes mellitus. 1 Some analytical methods are reported for its dosage: titrimetric, 2-5 spectrophotometric, [6] [7] [8] chromatographic, [9] [10] [11] [12] [13] [14] chemiluminescence, 15, 16 near-infrared reflectance 17 and capillary electrophoresis. 18 Spot-tests can be described as a way to rapidly detect the presence of an analyte in a drop of solution by contacting it with a suitable reagent. 19 Usually involving color forming and/or precipitation reactions and conducted in the form of spot-tests, the formed product is proportional to the concentration of the analyte. The common field of spot-tests is in qualitative analysis. The reactions are usually carried out with drops of the sample and of the reacting solutions on filter paper. In the past, attempts to obtain quantitative data directly form spot-tests by reflectance or transmittance measurements, on inert supports, yielded low relative precisions of 10 to 20%. 20 Therefore, quantitative results from conventional spot-test procedures have often been considered to be unreliable. The observed low precision on these kinds of measurements can be ascribed to effects of particle size and other surface phenomena on radiation reflectance. However, reflectance measurements are fast and easy to conduct.
Reflection takes place when light strikes a boundary surface, penetrates and subsequently reappears at the surface of the system after partial absorption and multiple scattering. In diffuse reflectance measurements, the reflectometer detects and measures the diffused reflected radiation, also called reflectance or reflection power, TR, which is analogous to transmittance in transmittance measurements. The optical density in reflectance mesasurements is AR = -log TR, similar to absorbance.
The reflecting power, TR, is given by TR = I/Io , where Io is the intensity of the incident radiation and I is the reflected intensity. TR lies between 0 and 1. TR is 1 whenever the absolute reflecting power can be measured from a standard reflecting surface, usually compressed BaSO4 or MgO powder.
In reflectance phenomena, the relationship between the sample concentration and the reflectance power is given by Kubelka-Munk equation, f(TR) = (1 -TR) 2 /2TR = εC/S, where ε is the molar absorptivity, C the sample concentration and S the scattering coefficient.
For relative measurements, as is the case of analytical determinations based on a calibration curve, the reflecting power can be considered equal to 1 for the reflecting material used as the blank, and many different calibration plots can be proposed to empirically fit TR or AR. [21] [22] [23] [24] [25] In the last twelve years, some successful quantitative spot-test reflectance procedures have been related, for inorganic and organic analytes, including the development of simple reflectometric equipment. [21] [22] [23] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] In the present work, a simple and reliable method based on UV-visible diffuse reflectance was developed for the determination of metformin hydrochloride in pharmaceutical preparations after reaction of this substance with Ni
2+
, forming a colored complex with maximum absorption at 425 nm.
experimental

Equipment
Detection was performed by coupling an Integration Sphere (Shimadzu, Model ISR-2200) to an UV-visible Shimadzu spectrophotometer, Model UV-2450. A micropipette holder ( Fig. 1 ) was used to drop solutions onto a support filter membrane with a micropipette, in a reproducible way. 21 The filter membrane was a Millipore glass micro-fiber filter membrane with 0.7 μm porosity and 25 mm diameter (AP4002500). A quantitative spot-test for the determination of metformin in pharmaceutical preparations using diffuse UV-visible reflectance is reported. The procedure is quite simple, involving in the formation of a metformin-nickel(II) complex on a glass filter membrane with a later measurement of the reflectance in the spectrophotometer using an integration sphere. The analytical results obtained with commercial products were statistically compared with those resulting from a method recommended by JP and by USP, where complete agreement was observed. The average RSD is 2.5% and the detection (0.009 mol L -1 ) and the quantitation (0.03 mol L -1 ) limits are quite adequate for pharmaceutical analysis. 
Notes
The mask used to support the filter membrane was made in our laboratory. It is consisted of a black PVC sheet of 0.3 mm thickness, 70 mm in high and 40 mm in width, containing a 15 by 10 mm window where a fixed area of the nickel complex was submitted to radiation. The mask is depicted in Fig. 2 .
Chemicals and solutions
All of the chemicals used were of analytical grade, except for metformin hydrochloride, which was an analyzed pharmaceutical product with 98.5% purity. This content was confirmed using the official method, 2,3 where the experimental value was 98.58%. A 1.0 mol L -1 stock nickel(II) solution was prepared by dissolving 11.88 g of NiCl2·6H2O in 50.0 mL of water.
A 0.510 mol L -1 stock metformin hydrochloride solution was prepared by dissolving 2.1489 g of the drug in water in a 25.04-mL volumetric flask.
Proposed procedure
From the stock metformin and nickel solutions, adequate concentrations of nickel(II) and metformin hydrochloride were prepared in a 10.03-mL volumetric flask by adding variable aliquots of a metformin solution, from 1.50 to 5.00 mL in 0.50 mL steps. They were mixed with 2.0 mL of the 1.0 mol L ). The volume was completed to the mark with distilled water. These solutions were called Ai (i = 1 to 8). An aqueous 2.0 mol L -1 sodium hydroxide solution was called B. These solutions, Ai and B, were used to construct the analytical curve.
The analytical reaction was done directly on the filter membrane in the following way: using a micropipette support, 150 μL of B solution was placed on the filter membrane, followed by 80 μL of the Ai solution. An orange precipitate corresponding to the metformin-nickel(II) complex immediately appeared. The membrane containing the precipitate was placed on a watch glass and dried at 60 C in an oven for 45 min. Higher temperatures were avoided, because they cause a deformation of the membrane. The absorbance of the reflected light was measured using a Shimadzu Integration Sphere coupled to a Shimadzu UV-visible spectrophotometer. The membrane was placed in the mask (Fig. 2) . The mask containing the membrane was introduced into, and removed from, the support in the Integration Sphere three times in order to obtain an average value of the reflectance (absorbance). Membranes treated with 150 μL of the B solution and also dried in the oven were used as blank.
Sample analyses
Twenty tablets were weighed and carefully pulverized in a mortar. The mean mass of each pharmaceutical preparation was considered for the calculations. An aliquot containing approximately 800 mg of metformin was weighed in order to obtain 10.03 mL (volumetric flask) of a 0.5 mol L -1 metformin hydrochloride solution.
The aliquot was placed in a small glass tube, and 2.0 mL of water was added, following vigorous shaking in order to extract the metformin hydrochloride. The tube was centrifuged and the supernatant was separated and transferred to a 10.03-mL volumetric flask. Extraction of the residual solid with 2.0 mL of distilled water was repeated three times, always while transferring the supernatant to the 10.03-mL volumetric flask. The volume was completed to the mark with distilled water, and 2.916 mL (3.0 mL pipette) was used to obtain a concentration corresponding to about 0.15 mol L -1 . The solutions obtained in this manner were treated exactly as done with solutions Ai. From the absorbance values, the metformin concentrations were obtained.
Recommended JP and USP method
According to JP 2 and to USP, 3 potentiometric titrations were also carried out. The titrant was 0.1 mol L -1 perchloric acid in glacial acetic acid, standardized with potassium biphthalate. 39 From the pulverized samples, a quantity containing approximately 60 mg of metformin hydrochloride was weighed. It was dissolved in a 150-mL beaker with 50 mL of acetic anhydride and 4 mL of formic acid. Titration was done with standardized perchloric acid.
Statistical analysis
The statistical Student's t-test and the Snedecor F-test 40 were applied to compare the recovery results obtained by the two analytical methods, the proposed method and the titrimetric method.
2,3
Results and Discussion
According to Abu-El-Wafa et al., 38 metformin forms stable complexes with copper, nickel, cobalt and zinc, stability of which follows the order Cu(II) > Ni(II) > Co(II) > Zn(II). The authors prepared these complexes using the ligand dissolved in water and the metal ions in ethanol. Precipitation was caused by adding a KOH solution. The observed precipitates presented the following colors: violet for Cu(II), yellow for Ni(II), reddish orange for Co(II) and colorless for Zn(II).
In the present work, copper, nickel and cobalt were tested according a method described by Abu-El-Wafa et al., 38 using excess metal with respect to the ligand ion in order to guarantee the quantitative precipitation of metformin. Under these conditions, the precipitation of the metal hydroxides was also observed. Using the method described in the experimental section above, the observed precipitates exhibited the following colors: Cu(II), reddish orange mixed with another clear precipitate, probably copper hydroxide (light blue); Ni(II), orange; Co(II), bright yellow and/or green color. The complex metformin-nickel(II) is clearly the best formed among the three and always shows the same color. Therefore, it was selected for developing the analytical method mentioned here.
Since 1-cyano guanidine is predicted to be an important contaminant in metformin preparations, tests were performed with this reagent, and it was observed that it did not precipitate with metformin under the conditions used in the method reported here. Therefore it does not interfere with the analytical results.
The analytical curve, obtained by reflectance at 425 nm with the proposed procedure is described by the equation A = 0.1060 + 0.9888C, where A is the absorbance value and C is the metformin concentration in mol L -1 in the measuring solution. The correlation coefficient is R = 0.9975. The observed absorbance values in the reflectance method varied from 0.183 to 0.353 with a mean standard deviation equal to 1.6%.
Two pharmaceutical preparations obtained in the local market were analyzed with the proposed and official methods. These preparations were treated as described in the experimental section. Five determinations were performed for each sample using the proposed reflectance method. Three determinations were performed per sample using the reference method. The results are given in Table 1 where statistical comparative treatments are also shown.
From the statistical Student's t-test at 95% confidence level, a complete agreement between the results obtained with the two methods was observed. From the Snedecor F-test, agreement between the precision of the two procedures was also verified. 40 The average RSD is 2.5%; the detection (0.009 mol L -1 ) and the quantitation (0.03 mol L -1 ) limits are quite adequate for pharmaceutical analysis.
The proposed method, compared to the official method, 2,3 can be considered to be an environmentally friendly procedure, since only water as solvent and small quantities of ammonium hydroxide and sodium hydroxide are used. The official method uses 4 mL of formic acid and 50 mL of acetic anhydride per determination.
conclusion
The proposed UV-visible diffuse reflectance method offers analytical results comparable to the official titrimetric procedure recommended by the Japanese 2 and by the United States Pharmacopoeias. 3 It is very simple to perform, low cost and presents low levels of toxicity and little environmental contamination.
Thus, it can be concluded that the UV-visible reflectance method proposed herein can be recommended for the determination of metformin in pharmaceutical preparations. Confidence level, 95%. Proposed method, n = 5 determinations; official method, n = 3 determinations; degree of freedom, n1 + n2 -2 = ν = 6. a. The tablet also contained microcrystalline cellulose, crospovidone, colloidal silicon dioxide, magnesium stearate, polyvinylpyrrolidone, croscarmelose sodium, and sodium starch glycolate. b. The tablet also contained microcrystalline cellulose, crospovidone, colloidal silicon dioxide, magnesium stearate, povidone, hypromellose, and polyethylene glycol.
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